Post-approval studies (Phase 4)Study completedNCT04230148
What this trial is testing
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).
Who this might be right for
Fascioliasis
Novartis Pharmaceuticals 301